Shenglan Yang

1.1k total citations · 2 hit papers
14 papers, 702 citations indexed

About

Shenglan Yang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Shenglan Yang has authored 14 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Epidemiology. Recurrent topics in Shenglan Yang's work include Inflammasome and immune disorders (3 papers), Respiratory Support and Mechanisms (2 papers) and Long-Term Effects of COVID-19 (2 papers). Shenglan Yang is often cited by papers focused on Inflammasome and immune disorders (3 papers), Respiratory Support and Mechanisms (2 papers) and Long-Term Effects of COVID-19 (2 papers). Shenglan Yang collaborates with scholars based in China and New Zealand. Shenglan Yang's co-authors include Luorui Shang, Fangyuan Zhou, Guangtao Pan, Yuhan Liu, Jinxiao Li, Shuhan Wang, Mengqi Zhang, Jiabin Zhou, Kunmin Xiao and Yuhan Liu and has published in prestigious journals such as Journal of Ethnopharmacology, Biomedicine & Pharmacotherapy and Journal of Experimental & Clinical Cancer Research.

In The Last Decade

Shenglan Yang

14 papers receiving 696 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EMT‐associated microRNAs and their roles in cancer stemness and drug resistance

2021 246 citations Guangtao Pan, Yuhan Liu et al. Cancer Communications profile →
Mechanism of Sijunzi Decoction in the treatment of colorectal cancer based on network pharmacology and experimental validation

2022 161 citations Luorui Shang, Jinxiao Li et al. Journal of Ethnopharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shenglan Yang China	9	412	172	102	93	75	14	702
Luorui Shang China	9	341 0.8×	166 1.0×	71 0.7×	96 1.0×	75 1.0×	16	582
Wei‐Jan Wang Taiwan	16	419 1.0×	151 0.9×	108 1.1×	104 1.1×	30 0.4×	42	842
Min Tan China	18	350 0.8×	139 0.8×	144 1.4×	113 1.2×	32 0.4×	57	856
Fangfang Liu China	19	381 0.9×	115 0.7×	105 1.0×	167 1.8×	37 0.5×	46	893
Qi He China	17	280 0.7×	91 0.5×	106 1.0×	60 0.6×	46 0.6×	61	730
Yifang Li China	13	207 0.5×	82 0.5×	106 1.0×	58 0.6×	60 0.8×	28	566
Neeraj Kapur United States	15	227 0.6×	85 0.5×	81 0.8×	212 2.3×	26 0.3×	36	750
Weiji Lin China	15	217 0.5×	46 0.3×	80 0.8×	78 0.8×	103 1.4×	29	744
Xin Ba China	16	276 0.7×	60 0.3×	59 0.6×	122 1.3×	113 1.5×	30	816

Countries citing papers authored by Shenglan Yang

Since Specialization

Citations

This map shows the geographic impact of Shenglan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenglan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenglan Yang more than expected).

Fields of papers citing papers by Shenglan Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenglan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenglan Yang. The network helps show where Shenglan Yang may publish in the future.

Co-authorship network of co-authors of Shenglan Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Shenglan Yang. A scholar is included among the top collaborators of Shenglan Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenglan Yang. Shenglan Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Li, Yongqi, Yuhan Jiang, Zhengxi Hu, et al.. (2025). Protein Kinase C Family: Structures, Biological Functions, Diseases, and Pharmaceutical Interventions. MedComm. 6(11). e70474–e70474. 1 indexed citations

Chen, Liuying, Zhongwei Yin, Luorui Shang, et al.. (2025). Intestinal Fut2 deficiency exacerbated alcohol‐related liver disease by disrupting nicotinamide metabolism. Clinical and Translational Medicine. 15(8). e70447–e70447. 1 indexed citations

Yang, Shenglan, et al.. (2025). Association Between Glycated Hemoglobin and Diabetic Retinopathy in Individuals with Diabetes: A Focus on the Modifying Effect of Ambulatory Blood Pressure. Clinical Interventions in Aging. Volume 20. 1029–1038. 1 indexed citations

Shang, Luorui, Jinxiao Li, Fangyuan Zhou, et al.. (2023). MiR-874-5p targets VDR/NLRP3 to reduce intestinal pyroptosis and improve intestinal barrier damage in sepsis. International Immunopharmacology. 121. 110424–110424. 8 indexed citations

Pan, Guangtao, et al.. (2023). Dachengqi decoction ameliorates sepsis-induced liver injury by inhibiting the TGF-β1/Smad3 pathways. Journal of Traditional and Complementary Medicine. 14(3). 256–265. 2 indexed citations

Shang, Luorui, Mengqi Zhang, Jinxiao Li, et al.. (2023). Dachengqi decoction alleviates acute lung injury by suppressing HIF-1α-mediated glycolysis. Journal of Ethnopharmacology. 321. 117410–117410. 9 indexed citations

Li, Jinxiao, Luorui Shang, Fangyuan Zhou, et al.. (2023). Herba Patriniae and its component Isovitexin show anti-colorectal cancer effects by inducing apoptosis and cell-cycle arrest via p53 activation. Biomedicine & Pharmacotherapy. 168. 115690–115690. 19 indexed citations

Zhou, Fangyuan, Haiyang Gao, Luorui Shang, et al.. (2023). Oridonin promotes endoplasmic reticulum stress via TP53-repressed TCF4 transactivation in colorectal cancer. Journal of Experimental & Clinical Cancer Research. 42(1). 150–150. 51 indexed citations

Shang, Luorui, Jinxiao Li, Fangyuan Zhou, et al.. (2022). Mechanism of Sijunzi Decoction in the treatment of colorectal cancer based on network pharmacology and experimental validation. Journal of Ethnopharmacology. 302(Pt A). 115876–115876. 161 indexed citations breakdown →

10.

Pan, Guangtao, Yuhan Liu, Luorui Shang, Fangyuan Zhou, & Shenglan Yang. (2021). EMT‐associated microRNAs and their roles in cancer stemness and drug resistance. Cancer Communications. 41(3). 199–217. 246 indexed citations breakdown →

11.

Liu, Yuhan, et al.. (2021). Emodin Attenuates LPS-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome-Dependent Pyroptosis Signaling Pathway In vitro and In vivo. Inflammation. 45(2). 753–767. 53 indexed citations

12.

Liu, Yuhan, et al.. (2021). Honokiol alleviates LPS-induced acute lung injury by inhibiting NLRP3 inflammasome-mediated pyroptosis via Nrf2 activation in vitro and in vivo. Chinese Medicine. 16(1). 127–127. 78 indexed citations

13.

Zhou, Fangyuan, Meihui Tao, Luorui Shang, et al.. (2021). Assessment of Sequelae of COVID-19 Nearly 1 Year After Diagnosis. Frontiers in Medicine. 8. 717194–717194. 57 indexed citations

14.

Wang, Li, et al.. (2021). Long‐term effects of obesity on COVID‐19 patients discharged from hospital. Immunity Inflammation and Disease. 9(4). 1678–1685. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact